An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial

Added 73 days ago (06.07.2021)
Authors: Ilad Alavi Darazam; Firouze Hatami; Mohammad Mahdi Rabiei; Mohamad Amin Pourhoseingholi; Minoosh Shabani; Shervin Shokouhi; Masoud Mardani; Omid Moradi; Farid Javandoust Gharehbagh; Nasrinsadat Mirtalaee; Halimeh Negahban; Mahdi Amirdosara; Masoud Zangi; Mohammadreza Hajiesmaeili; Muhanna Kazempour; Navid Shafigh
Read article